Back to Markets
ABAbivax SA

Abivax SA

ABVXNYSE EURONEXT - EURONEXT PARIS
Health CareBiotechnology

$132.63

+3.13 (+2.42%)

As of 05/29/26 EDT · USD

Compare
Low: $5.69Current: $132.63High: $148.83

Key Statistics

Open

$130.61

Day High

$133.50

Day Low

$127.89

Prev. Close

$129.50

VolumeShares traded today.

1.80M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$10.52B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$148.83

52W LowLowest price over the past 52 weeks.

$5.69

50D MAAverage closing price over the last 50 trading days.

$118.32

200D MAAverage closing price over the last 200 trading days.

$109.28

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+6.9%

1M

+24.8%

6M

+3.4%

YTD

-0.9%

1Y

+1988.7%

About

Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

www.abivax.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNYSE EURONEXT - EURONEXT PARIS
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ABVX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.